Alzheimer's, Parkinson's disease, multiple sclerosis and traumatic brain injury are four neurodegenerative disorders with very different – and very devastating – effects on the brain and daily life. While there are multiple treatments and therapies aimed at fighting each of these conditions separately, a team of researchers from Northwestern University Feinberg School of Medicine have developed a new "one-size-fits-all" therapy drug that could potentially treat all of them
No comments:
Post a Comment